Correlation Between Orchestra BioMed and NetSol Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orchestra BioMed and NetSol Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orchestra BioMed and NetSol Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orchestra BioMed Holdings and NetSol Technologies, you can compare the effects of market volatilities on Orchestra BioMed and NetSol Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orchestra BioMed with a short position of NetSol Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orchestra BioMed and NetSol Technologies.

Diversification Opportunities for Orchestra BioMed and NetSol Technologies

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Orchestra and NetSol is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Orchestra BioMed Holdings and NetSol Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NetSol Technologies and Orchestra BioMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orchestra BioMed Holdings are associated (or correlated) with NetSol Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NetSol Technologies has no effect on the direction of Orchestra BioMed i.e., Orchestra BioMed and NetSol Technologies go up and down completely randomly.

Pair Corralation between Orchestra BioMed and NetSol Technologies

Given the investment horizon of 90 days Orchestra BioMed Holdings is expected to under-perform the NetSol Technologies. In addition to that, Orchestra BioMed is 3.49 times more volatile than NetSol Technologies. It trades about -0.09 of its total potential returns per unit of risk. NetSol Technologies is currently generating about 0.1 per unit of volatility. If you would invest  269.00  in NetSol Technologies on September 16, 2024 and sell it today you would earn a total of  7.00  from holding NetSol Technologies or generate 2.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Orchestra BioMed Holdings  vs.  NetSol Technologies

 Performance 
       Timeline  
Orchestra BioMed Holdings 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Orchestra BioMed Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting forward indicators, Orchestra BioMed displayed solid returns over the last few months and may actually be approaching a breakup point.
NetSol Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NetSol Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, NetSol Technologies is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Orchestra BioMed and NetSol Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orchestra BioMed and NetSol Technologies

The main advantage of trading using opposite Orchestra BioMed and NetSol Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orchestra BioMed position performs unexpectedly, NetSol Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NetSol Technologies will offset losses from the drop in NetSol Technologies' long position.
The idea behind Orchestra BioMed Holdings and NetSol Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories